1,800
Participants
Start Date
June 9, 2025
Primary Completion Date
April 1, 2027
Study Completion Date
June 1, 2029
rifampin standard arm
120 doses daily self-administered rifampin at 10mg/kg/day (max 600mg/day)
rifampin double dose
60 doses daily self-administered rifampin at 20 mg/kg (max. 1200 mg/day)
levofloxacin and rifapentine
30 doses daily self-administered levofloxacin (15 mg/kg, max 750mg/day and rifapentine (10mg/kg, max: 600mg)
Centre National Hospitalier Universitaire de Pneumo Phtisiologie de Cotonou (CNHU-PPC), Cotonou
Manaus, Manaus
Unviversity of Calgary, Calgary
BCCDC TB clinic, Vancouver
University of Manitoba, Winnipeg
University of Ottawa, Ottawa
Universitas Padjadjaran, Klinik Penelitian Tuberculosis (TB research clinic), Bandung
Vietnam, Ho Chi Minh City
The Governors of the University of Alberta, Edmonton
St. Michael's Hospital, Toronto
University Health Network, Toronto
MUHC, Montreal
Hopital du Sacré-Coeur de Montreal, Montreal
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER